David McIntosh: PPTA Calls for Action on the Global Shortage of Plasma-Derived Medicines
David McIntosh, Founder and Chair at United Plasma Action, shared Plasma Protein Therapeutics Association’s post on LinkedIn:
“Huge thanks and congratulations are due to the PPTA team, the authors and editors for this milestone post, especially to Doctor Hartmann.
In a World where millions die each year because of chronic global shortages of Plasma-Derived Medicines – and where many authorities appear not yet to have woken up to this shameful fact – it is very encouraging to see the premier industry representative organisation speaking up in this way.
Given that 90% of the current global supply of pharmaceutical grade plasma comes to us thanks to the commercial Plasma Industry, their representative is certainly well placed to speak up.
All we need now is for the WHO, the EU and Governments round the World to actually stop, look and listen up – pay due attention to the evidence – and ACT accordingly.
Millions of lives depend upon their doing so…”
Plasma Protein Therapeutics Association (PPTA) shared a post on LinkedIn:
“A secure supply of source plasma is fundamental to ensuring patients have access to plasma-derived medicines.
The Annals of Blood special series on Source Plasma examines the many factors that shape this critical supply. From collection and donor safety to regulation, manufacturing, pathogen safety, and access, expert papers detail the complex global plasma web.
Julia Fabens, Michelle Fransen, James Knowles, Evelina Kozubovska, Joshua Penrod, Crystal Phillips, Dr. Toby Simon, and Halide Tuna, contributed their expertise to this important, ongoing conversation.
Read the series to explore the challenges and opportunities shaping the future of source plasma.”
Other posts featuring David McIntosh on Hemostasis Today.
-
Oct 24, 2026, 16:57Pall T. Onundarson: Fiix Prothrombin Time Advancing Precision in Anticoagulation Management
-
Oct 24, 2026, 16:42Mark-Anthony Johnson: Blood Type Awareness and Emergency Transfusion
-
Oct 24, 2026, 16:27Pedro Perez: Florida’s Push to Strengthen VTE Prevention
-
Oct 24, 2026, 16:23Kathleen Freson: Human Cell Models Advance Research into Rare Platelet Disorders
-
Oct 24, 2026, 16:18Victor Daniel: Deep Learning for Automated Platelet Classification
-
Oct 24, 2026, 16:08Paula Alonso-Frías: Human Umbilical Cord Blood Platelet-Rich Plasma for Endometrial Regeneration
-
Oct 24, 2026, 16:00Fatma Ebeid: Ain Shams University Hosts TIF Experts for Collaborating Center Evaluation
-
Oct 24, 2026, 15:52Mazen A. Juratli: Platelet-Derived Extracellular Vesicles as Potential Predictors of Survival in Liver Cancer
-
Oct 24, 2026, 14:28Satyam Arora: Umbilical Cord Blood for Neonatal Transfusions